Impact of Typical and Atypical Complex Karyotype Subgroups on Outcome of AML Patients Undergoing Allogeneic Stem Cell Transplantation

被引：0
|
作者：
Ussmann, Jule [1 ]
Weigert, Anne [1 ]
Bischof, Lara [1 ]
Brauer, Dominic [1 ]
Backhaus, Donata [1 ]
Diener, Claudia [1 ]
Merz, Maximilian [1 ]
Vucinic, Vladan [1 ]
Metzeler, Klaus H. [1 ]
Platzbecker, Uwe [2 ]
Schwind, Sebastian [1 ]
Jentzsch, Madlen [1 ]
机构：
[1] Univ Leipzig, Med Ctr, Dept Hematol Cell Therapy Hemostaseol & Infect Di, Leipzig, Germany
[2] Univ Med Ctr Leipzig, Dept Hematol Cellular Therapy Hemostaseol & Infec, Leipzig, Germany
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-179713
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Monosomal Karyotype Provides Better Prognostic Prediction After Allogeneic Stem Cell Transplantation in AML Patients
    Oran, Betul
    Dolan, Michelle
    Ma, Linan
    Brunstein, Claudio
    Warlick, Erica
    Weisdorf, Daniel J.
    BLOOD, 2009, 114 (22) : 218 - 219
  • [22] Impact of Cytomegalovirus serological status and viral reactivation on outcome of AML patients after allogeneic stem cell transplantation
    Guenounou, S.
    Berard, E.
    Yon, E.
    Bertoli, S.
    Recher, C.
    Borel, C.
    Huynh, A.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S481 - S481
  • [23] Impact of antithymocyte globulin induced hyperbilirubinemia on outcome of patients undergoing allogeneic hematopoietic stem cell transplantation
    Manjara, I.
    Zabelina, T.
    Bacher, U.
    Kroeger, N.
    Zander, A. R.
    Ayuk, F.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S403 - S403
  • [24] OUTCOME OF PATIENTS WITH IDH-MUTATED AML FOLLOWING ALLOGENEIC STEM CELL TRANSPLANTATION
    Schroeder, Thomas
    Flossdorf, Sarah
    Pabst, Caroline
    Stadler, Michael
    Schetelig, Johannes
    Wehr, Claudia
    Schuh, Claudia
    Stelljes, Matthias
    Sala, Elisa
    Burchert, Andreas
    Kaivers, Jennifer
    Reinhardt, Christian
    Kroeger, Nicolaus
    Fleischhauer, Katharina
    Rautenberg, Christina
    BONE MARROW TRANSPLANTATION, 2024, 59 : 145 - 146
  • [25] Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML
    Morsink, Linde M.
    Othus, Megan
    Bezerra, Evandro D.
    Wood, Brent L.
    Fang, Min
    Sandmaier, Brenda M.
    Mielcarek, Marco
    Schoch, Gary
    Storb, Rainer
    Deeg, H. Joachim
    Appelbaum, Frederick R.
    Walter, Roland B.
    LEUKEMIA, 2020, 34 (06) : 1577 - 1587
  • [26] Impact of pretransplant measurable residual disease on the outcome of allogeneic hematopoietic cell transplantation in adult monosomal karyotype AML
    Linde M. Morsink
    Megan Othus
    Evandro D. Bezerra
    Brent L. Wood
    Min Fang
    Brenda M. Sandmaier
    Marco Mielcarek
    Gary Schoch
    Rainer Storb
    H. Joachim Deeg
    Frederick R. Appelbaum
    Roland B. Walter
    Leukemia, 2020, 34 : 1577 - 1587
  • [27] Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
    Desiree Kunadt
    Sebastian Stasik
    Klaus H. Metzeler
    Christoph Röllig
    Christoph Schliemann
    Philipp A. Greif
    Karsten Spiekermann
    Maja Rothenberg-Thurley
    Utz Krug
    Jan Braess
    Alwin Krämer
    Andreas Hochhaus
    Sebastian Scholl
    Inken Hilgendorf
    Tim H. Brümmendorf
    Edgar Jost
    Björn Steffen
    Gesine Bug
    Hermann Einsele
    Dennis Görlich
    Cristina Sauerland
    Kerstin Schäfer-Eckart
    Stefan W. Krause
    Mathias Hänel
    Maher Hanoun
    Martin Kaufmann
    Bernhard Wörmann
    Michael Kramer
    Katja Sockel
    Katharina Egger-Heidrich
    Tobias Herold
    Gerhard Ehninger
    Andreas Burchert
    Uwe Platzbecker
    Wolfgang E. Berdel
    Carsten Müller-Tidow
    Wolfgang Hiddemann
    Hubert Serve
    Matthias Stelljes
    Claudia D. Baldus
    Andreas Neubauer
    Johannes Schetelig
    Christian Thiede
    Martin Bornhäuser
    Jan M. Middeke
    Friedrich Stölzel
    Journal of Hematology & Oncology, 15
  • [28] Impact of IDH1 and IDH2 mutational subgroups in AML patients after allogeneic stem cell transplantation
    Kunadt, Desiree
    Stasik, Sebastian
    Metzeler, Klaus H.
    Roellig, Christoph
    Schliemann, Christoph
    Greif, Philipp A.
    Spiekermann, Karsten
    Rothenberg-Thurley, Maja
    Krug, Utz
    Braess, Jan
    Kraemer, Alwin
    Hochhaus, Andreas
    Scholl, Sebastian
    Hilgendorf, Inken
    Bruemmendorf, Tim H.
    Jost, Edgar
    Steffen, Bjoern
    Bug, Gesine
    Einsele, Hermann
    Goerlich, Dennis
    Sauerland, Cristina
    Schaefer-Eckart, Kerstin
    Krause, Stefan W.
    Haenel, Mathias
    Hanoun, Maher
    Kaufmann, Martin
    Woermann, Bernhard
    Kramer, Michael
    Sockel, Katja
    Egger-Heidrich, Katharina
    Herold, Tobias
    Ehninger, Gerhard
    Burchert, Andreas
    Platzbecker, Uwe
    Berdel, Wolfgang E.
    Mueller-Tidow, Carsten
    Hiddemann, Wolfgang
    Serve, Hubert
    Stelljes, Matthias
    Baldus, Claudia D.
    Neubauer, Andreas
    Schetelig, Johannes
    Thiede, Christian
    Bornhaeuser, Martin
    Middeke, Jan M.
    Stoelzel, Friedrich
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
  • [29] Outcome of allogeneic stem cell transplantation in myelodysplastic syndrome patients: prognostic implication of monosomal karyotype
    Wudhikarn, Kitsada
    Van Rheeden, Richard
    Leopold, Christina
    Rattanaumpawan, Pinyo
    Gingrich, Roger
    Silverman, Margarida de Magalhaes
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (04) : 294 - 301
  • [30] HLA Evolutionary Divergence as a Prognostic Marker for AML Patients Undergoing Allogeneic Stem Cell Transplantation
    Roerden, Malte
    Nelde, Annika
    Heitmann, Jonas S.
    Klein, Reinhild
    Rammensee, Hans-Georg
    Bethge, Wolfgang A.
    Walz, Juliane S.
    CANCERS, 2020, 12 (07) : 1 - 10
12345